Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Interventional cardiology Stories

2013-10-23 16:29:31

More Interventional Cardiologists Are Performing Transradial Angioplasty, Sparking Need for Guidance to Prevent Complications and Optimize Patient Care WASHINGTON, Oct. 23, 2013 /PRNewswire/ -- Today the Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices for the use of the transradial approach for diagnosing and treating blocked heart arteries, which involves accessing the arteries via an artery in the wrist....

2013-10-23 12:29:59

DUBLIN, October 23, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/p4xrbt/interventional) has announced the addition of the "Interventional Cardiology Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" [http://www.researchandmarkets.com/research/p4xrbt/interventional ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The BRICSS...

2013-10-17 23:28:38

Global LVAD Market Report: 2013 Edition and Robotic Surgery Market Report: 2013 Edition are the new research reports available with MarketReportsOnline.com. Dallas, Texas (PRWEB) October 17, 2013 LVADs are the mechanical devices which are implanted into the abdomen or chest and attached to a weakened heart to help it pump. LVADs are now sometimes used as an alternative to transplantation. LVAD is suitable for bridge-to-transplant market, which extends the patient’s life until a suitable...

2013-10-17 16:25:18

PLEASANTON, Calif., Oct. 17, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the third quarter of fiscal year 2013 on Wednesday, October 30. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific...

2013-10-16 08:23:29

The Market Entrance of Drug-Eluting Stents and Drug-Coated Balloons In the Near Future Will Boost Revenue Growth, According to Millennium Research Group TORONTO, Oct. 16, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Asia Pacific market for peripheral vascular (PV) devices is largely underpenetrated and will therefore expand rapidly through 2022 as demand for PV procedures rises. Strong economic...

2013-10-15 16:26:12

Angioplasty and bypass surgery can lead to similar longterm benefits, finds study led by Saint Luke's Mid America Heart Institute researchers published in Journal of the American Medical Association KANSAS CITY, Mo., Oct. 15, 2013 /PRNewswire-USNewswire/ -- For patients with diabetes and coronary artery disease in more than one artery, treatment with coronary artery bypass graft (CABG) surgery provided slightly better health status and quality of life between six months and two...

2013-10-15 12:32:35

Distinguished Healthcare Executive Takes the Helm at Pioneering Foundation in Interventional Cardiology NEW YORK, Oct. 15, 2013 /PRNewswire-USNewswire/ -- The Cardiovascular Research Foundation (CRF) today announced the appointment of John (Jack) C. Lewin, MD, as the foundation's President and Chief Executive Officer. Dr. Lewin was also appointed to CRF's Board of Directors. A leading medical and healthcare expert, Dr. Lewin brings a unique blend of leadership and management skills...

2013-10-09 23:20:37

Reportbuyer.com just published a new market research report: Research on China Coronary Stent Industry, 2013-2017 (Update). London (PRWEB) October 09, 2013 The demand for interventional medical core products has increased continuously with the improvement of living quality and the coming of aging society; PCI (percutaneous coronary intervention) surgical cases also increased year by year. In 2012, the usage quantity of coronary stent was about 633,600 sets and the market scale reached CNY...

2013-10-09 20:22:35

MAJESTIC Trial To Study Self-Expanding DES System Designed To Treat Superficial Femoral Artery (SFA) Lesions NATICK, Mass., Oct. 9, 2013 /PRNewswire/ -- Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the Boston Scientific Corporation (NYSE: BSX) Innova(TM) Drug-Eluting Stent (DES) System. The MAJESTIC trial -- designed to evaluate the safety and...

2013-10-08 20:21:57

DUBLIN, October 8, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5w2328/cardiac_medical) has announced the addition of the "Cardiac Medical Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" [http://www.researchandmarkets.com/research/5w2328/cardiac_medical ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) BRICSS Cardiac Medical...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »